Novo Nordisk
NVO
#78
Rank
โ‚น21.467 T
Marketcap
โ‚น4,853
Share price
-2.25%
Change (1 day)
-13.23%
Change (1 year)

Novo Nordisk A / S produces and markets pharmaceutical products and services. Since its founding in Denmark in 1923, the company has developed into a leading company in the diabetes sector worldwide.

Earnings for Novo Nordisk (NVO)

Earnings in 2026 (TTM): โ‚น2.254 Trillion

According to Novo Nordisk's latest financial reports the company's current earnings are โ‚น51.37 Billion. In 2025 the company made an earning of โ‚น2.021 Trillion, an increase over its 2024 earnings that were of โ‚น1.901 Trillion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Novo Nordisk from 1984 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) โ‚น2.254 T11.54%
2025 โ‚น2.021 T6.28%
2024 โ‚น1.901 T28.01%
2023 โ‚น1.485 T57.81%
2022 โ‚น941.50 B5.24%
2021 โ‚น894.66 B12.38%
2020 โ‚น796.08 B13.11%
2019 โ‚น703.82 B-3.45%
2018 โ‚น728.97 B1.88%
2017 โ‚น715.49 B4.3%
2016 โ‚น685.97 B10.32%
2015 โ‚น621.79 B7.47%
2014 โ‚น578.59 B3.4%
2013 โ‚น559.56 B19.09%
2012 โ‚น469.87 B15.58%
2011 โ‚น406.54 B16.58%
2010 โ‚น348.73 B25.66%
2009 โ‚น277.53 B10.68%
2008 โ‚น250.75 B55.82%
2007 โ‚น160.93 B7.02%
2006 โ‚น150.37 B19.05%
2005 โ‚น126.30 B10.55%
2004 โ‚น114.25 B
2002 โ‚น77.86 B-14.39%
2001 โ‚น90.94 B-52.82%
2000 โ‚น192.74 B250%
1999 โ‚น55.06 B31.21%
1998 โ‚น41.96 B34.31%
1997 โ‚น31.24 B11.46%
1996 โ‚น28.03 B9.03%
1995 โ‚น25.71 B-3.15%
1994 โ‚น26.54 B-0.67%
1993 โ‚น26.72 B45.38%
1992 โ‚น18.38 B-13.81%
1991 โ‚น21.32 B37.12%
1990 โ‚น15.55 B-0.79%
1989 โ‚น15.67 B26.2%
1988 โ‚น12.42 B24.97%
1987 โ‚น9.94 B-0.9%
1986 โ‚น10.03 B-7.78%
1985 โ‚น10.87 B24.87%
1984 โ‚น8.71 B

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
โ‚น1.021 T-57.66%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
โ‚น3.001 T 24.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
โ‚น738.54 B-69.38%๐Ÿ‡ซ๐Ÿ‡ท France
Bristol-Myers Squibb
BMY
โ‚น925.48 B-61.63%๐Ÿ‡บ๐Ÿ‡ธ USA